Fleur Chandler

London, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 9 publications

Valuing Child and Adolescent Health States to Derive Utilities for Use in Economic Evaluation: A Good Practices Report of an ISPOR Task Force.

Valuing Child and Adolescent Health States to Derive Utilities for Use in Economic Evaluation: A Good Practices Report of an ISPOR Task Force.

Journal: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research

Published: December 05, 2025

Understanding the health-related quality of life impacts of caring for children and adolescents with rare progressive life-limiting conditions: key challenges and future research priorities.

Understanding the health-related quality of life impacts of caring for children and adolescents with rare progressive life-limiting conditions: key challenges and future research priorities.

Journal: Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation

Published: February 19, 2025

Correction: Developing a Natural History Model for Duchenne Muscular Dystrophy.

Correction: Developing a Natural History Model for Duchenne Muscular Dystrophy.

Journal: PharmacoEconomics - open

Published: July 03, 2024

Developing a Natural History Model for Duchenne Muscular Dystrophy.

Developing a Natural History Model for Duchenne Muscular Dystrophy.

Journal: PharmacoEconomics - open

Published: October 18, 2023

The Challenge for Orphan Drugs Remains: Three Case Studies Demonstrating the Impact of Changes to NICE Methods and Processes and Alternative Mechanisms to Value Orphan Products.

The Challenge for Orphan Drugs Remains: Three Case Studies Demonstrating the Impact of Changes to NICE Methods and Processes and Alternative Mechanisms to Value Orphan Products.

Journal: PharmacoEconomics - open

Published: September 26, 2022

Measuring What Matters: Little Evidence Supporting the Content Validity of EQ-5D in People with Duchenne Muscular Dystrophy and Their Caregivers.

Measuring What Matters: Little Evidence Supporting the Content Validity of EQ-5D in People with Duchenne Muscular Dystrophy and Their Caregivers.

Journal: Medical decision making : an international journal of the Society for Medical Decision Making

Published: November 27, 2021

Survival after acute episodes of immune-mediated thrombotic thrombocytopenic purpura (iTTP) - cognitive functioning and health-related quality of life impact: a descriptive cross-sectional survey of adults living with iTTP in the United Kingdom.

Survival after acute episodes of immune-mediated thrombotic thrombocytopenic purpura (iTTP) - cognitive functioning and health-related quality of life impact: a descriptive cross-sectional survey of adults living with iTTP in the United Kingdom.

Journal: Hematology (Amsterdam, Netherlands)

Published: July 09, 2021

Development of a New Quality of Life Measure for Duchenne Muscular Dystrophy Using Mixed Methods: The DMD-QoL.

Development of a New Quality of Life Measure for Duchenne Muscular Dystrophy Using Mixed Methods: The DMD-QoL.

Journal: Neurology

Published: November 25, 2020

Sharing is Caring: The Case for Company-Level Collaboration in Pharmacoeconomic Modelling.

Sharing is Caring: The Case for Company-Level Collaboration in Pharmacoeconomic Modelling.

Journal: PharmacoEconomics

Published: May 22, 2017

Showing 1-9 of 9

Last Updated: 09/26/2026